Who Supplies Hydroxychloroquine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Hydroxychloroquine exports, with 163+ registered manufacturers shipping to buyers across 86+ countries — yet a handful of companies dominate the shipments. ZYDUS LIFESCIENCES LIMITED holds the largest share at 78.3% (export value: $110.7M). Close behind, CADILA HEALTHCARE LIMITED (4.5%, $6.3M). IPCA LABORATORIES LIMITED (4.1%, $5.7M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Hydroxychloroquine? Top Manufacturers & Their Buyers
Flow of Hydroxychloroquine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Hydroxychloroquine Supplier Network — Key Market Intelligence
The Hydroxychloroquine export market from India is led by ZYDUS LIFESCIENCES LIMITED, which alone commands a 78.3% share, shipping $110.7M worth of product across 259 shipments. The second-largest exporter, CADILA HEALTHCARE LIMITED, contributes $6.3M (4.5%) to the overall market. Combined, the top two suppliers alone account for 82.7% of all Hydroxychloroquine exports, indicating a relatively concentrated supply base.
Across all 163 tracked manufacturers, the total Hydroxychloroquine export value stands at $141.5M from 3.7K shipments. The market average shipment value is $38.1K. The single largest buyer relationship in terms of trade value is EVERSANA LIFE SCIENCES SERVICES LLC, receiving $104.6M worth of product.
The combined buyer network spans 13 named purchasing companies, including EVERSANA LIFE SCIENCES SERVICES LLC, NORTHSTAR DISTRIBUTION CENTER 8912, SARL CPCM, PRIORITY HEALTHCARE DISTRIBUTION, KASPA PHARMACEUTICAL (THAILAND) and 8 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the first-largest Hydroxychloroquine exporter from India, with a market share of 78.3% and a total export value of $110.7M across 259 shipments. Their average shipment value of $427.6K is above the market average of $38.1K, suggesting premium or bulk contract pricing.
ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 94.4% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $104.6M across 245 shipments (94.4% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $4.4M across 10 shipments (3.9% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES LLC — $638.2K across 1 shipments (0.6% of this supplier's total exports)
• SARL CPCM — $612.4K across 1 shipments (0.6% of this supplier's total exports)
• PRIORITY HEALTHCARE DISTRIBUTION — $537.1K across 1 shipments (0.5% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $427.6K is 1023% above the market average of $38.1K, consistent with large-order contracts or value-added formulations.
2CADILA HEALTHCARE LIMITED
CADILA HEALTHCARE LIMITED is the second-largest Hydroxychloroquine exporter from India, with a market share of 4.5% and a total export value of $6.3M across 40 shipments. Their average shipment value of $157.6K is above the market average of $38.1K, suggesting premium or bulk contract pricing.
CADILA HEALTHCARE LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 84.6% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $5.3M across 34 shipments (84.6% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $280.9K across 2 shipments (4.5% of this supplier's total exports)
• PRIORITY HEALTHCARE DISTRIBUTION — $277.5K across 2 shipments (4.4% of this supplier's total exports)
• KASPA PHARMACEUTICAL (THAILAND) — $208.0K across 1 shipments (3.3% of this supplier's total exports)
• HAPHARCO J S C BRANCH — $205.7K across 1 shipments (3.3% of this supplier's total exports)
Key Insight: CADILA HEALTHCARE LIMITED's per-shipment value of $157.6K is 314% above the market average of $38.1K, consistent with large-order contracts or value-added formulations.
3IPCA LABORATORIES LIMITED
IPCA LABORATORIES LIMITED is the third-largest Hydroxychloroquine exporter from India, with a market share of 4.1% and a total export value of $5.7M across 146 shipments. Their average shipment value of $39.3K is above the market average of $38.1K, suggesting premium or bulk contract pricing.
IPCA LABORATORIES LIMITED serves 5 named buyers in our database. NA is the dominant customer, accounting for 55.8% of this supplier's tracked business. Top customers include:
• NA — $3.2M across 81 shipments (55.8% of this supplier's total exports)
• IPCA LABORATORIES UK LIMITED — $1.7M across 43 shipments (29.4% of this supplier's total exports)
• TO THE ORDER — $295.9K across 8 shipments (5.2% of this supplier's total exports)
• PHARMA S INDUSTRIJSKA CESTA — $288.4K across 7 shipments (5.0% of this supplier's total exports)
• NADA — $265.1K across 7 shipments (4.6% of this supplier's total exports)
Key Insight: IPCA LABORATORIES LIMITED's per-shipment value of $39.3K is 3% above the market average of $38.1K, consistent with large-order contracts or value-added formulations.
4CADILA HEALTHCARE LTD
CADILA HEALTHCARE LTD is the fourth-largest Hydroxychloroquine exporter from India, with a market share of 1.9% and a total export value of $2.8M across 14 shipments. Their average shipment value of $196.7K is above the market average of $38.1K, suggesting premium or bulk contract pricing.
CADILA HEALTHCARE LTD serves 4 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 76.7% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $2.1M across 11 shipments (76.7% of this supplier's total exports)
• HAPHARCO J S C BRANCH — $518.6K across 3 shipments (18.8% of this supplier's total exports)
• KASPA PHARMACEUTICAL (THAILAND) — $88.6K across 0 shipments (3.2% of this supplier's total exports)
• SUNSHINE HEALTHCARE — $35.5K across 0 shipments (1.3% of this supplier's total exports)
Key Insight: CADILA HEALTHCARE LTD's per-shipment value of $196.7K is 417% above the market average of $38.1K, consistent with large-order contracts or value-added formulations.
5INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the fifth-largest Hydroxychloroquine exporter from India, with a market share of 0.6% and a total export value of $898.4K across 21 shipments. Their average shipment value of $42.8K is above the market average of $38.1K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $369.3K across 9 shipments (41.1% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES LLC — $368.9K across 9 shipments (41.1% of this supplier's total exports)
• TO THE ORDER — $143.6K across 3 shipments (16.0% of this supplier's total exports)
• NORA PHARMA INC — $16.6K across 0 shipments (1.8% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $42.8K is 12% above the market average of $38.1K, consistent with large-order contracts or value-added formulations.
6SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Hydroxychloroquine exporter from India, with a market share of 0.3% and a total export value of $423.1K across 14 shipments. Their average shipment value of $30.2K is below the market average of $38.1K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• RANBAXY (THAILAND) CO., LTD. — $172.0K across 6 shipments (40.7% of this supplier's total exports)
• RANBAXY THAILAND CO — $152.7K across 5 shipments (36.1% of this supplier's total exports)
• RANBAXY (THAILAND) CO., LTD. — $59.6K across 2 shipments (14.1% of this supplier's total exports)
• RANBAXY (THAILAND) CO., LTD. — $38.8K across 1 shipments (9.2% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (14 shipments) at a per-shipment value of $30.2K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Hydroxychloroquine Flows
Once Hydroxychloroquine leaves the manufacturing plants of companies like ZYDUS LIFESCIENCES LIMITED and CADILA HEALTHCARE LIMITED, it travels to 5 destination markets with a combined import value of $141.5M. United States absorbs the largest share at 89.2% ($126.2M), followed by United Kingdom (1.9%) and Thailand (1.5%).
In United States — the top destination — named importers include EVERSANA LIFE SCIENCE SERVICES, NORTHSTAR DISTRIBUTION CENTER 8912, EVERSANA LIFE SCIENCE SERVICES,. In United Kingdom, key buyers are IPCA LABORATORIES UK LIMITED.
This geographic spread reflects Hydroxychloroquine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Hydroxychloroquine Go? Top Importing Countries & Their Buyers
Trade flow of Hydroxychloroquine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Hydroxychloroquine imports from India, with a total trade value of $126.2M across 273 shipments — representing a 89.2% share of all Hydroxychloroquine exports. The average shipment value of $462.2K is above the global average of $38.1K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.
Named Hydroxychloroquine importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 90.7% ($114.4M) of this market's total imports.
• EVERSANA LIFE SCIENCE SERVICES — $114.4M (90.7% of United States's total)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $4.4M (3.5% of United States's total)
• EVERSANA LIFE SCIENCE SERVICES, — $1.3M (1.0% of United States's total)
Key Insight: United States's per-shipment average of $462.2K (1114% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Hydroxychloroquine imports from India.
2United Kingdom
United Kingdom ranks as the second-largest destination for Hydroxychloroquine imports from India, with a total trade value of $2.6M across 55 shipments — representing a 1.9% share of all Hydroxychloroquine exports. The average shipment value of $48.0K is above the global average of $38.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Hydroxychloroquine importers in United Kingdom: IPCA LABORATORIES UK LIMITED is the largest buyer, accounting for 99.8% ($2.6M) of this market's total imports.
• IPCA LABORATORIES UK LIMITED — $2.6M (99.8% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $48.0K (26% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Hydroxychloroquine imports from India.
3Thailand
Thailand ranks as the third-largest destination for Hydroxychloroquine imports from India, with a total trade value of $2.1M across 16 shipments — representing a 1.5% share of all Hydroxychloroquine exports. The average shipment value of $129.1K is above the global average of $38.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Hydroxychloroquine importers in Thailand: RANBAXY (THAILAND) CO., LTD. is the largest buyer, accounting for 46.5% ($960.2K) of this market's total imports.
• RANBAXY (THAILAND) CO., LTD. — $960.2K (46.5% of Thailand's total)
• KASPA PHARMACEUTICAL (THAILAND) — $338.4K (16.4% of Thailand's total)
Key Insight: Thailand's per-shipment average of $129.1K (239% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Hydroxychloroquine imports from India.
4Vietnam
Vietnam ranks as the fourth-largest destination for Hydroxychloroquine imports from India, with a total trade value of $2.0M across 15 shipments — representing a 1.4% share of all Hydroxychloroquine exports. The average shipment value of $130.6K is above the global average of $38.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Hydroxychloroquine importers in Vietnam: HAPHARCO J.S.C. BRANCH is the largest buyer, accounting for 42.4% ($831.2K) of this market's total imports.
• HAPHARCO J.S.C. BRANCH — $831.2K (42.4% of Vietnam's total)
• HAPHARCOJ S CBRANCH — $518.6K (26.5% of Vietnam's total)
• HAPHARCO J S C BRANCH — $372.7K (19.0% of Vietnam's total)
Key Insight: Vietnam's per-shipment average of $130.6K (243% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Vietnam is a key market for Hydroxychloroquine imports from India.
5Germany
Germany ranks as the fifth-largest destination for Hydroxychloroquine imports from India, with a total trade value of $1.7M across 0 shipments — representing a 1.2% share of all Hydroxychloroquine exports. The average shipment value of $1.7M is above the global average of $38.1K, indicating high-value procurement contracts or branded formulations.
Key Insight: Germany's per-shipment average of $1.7M (4394% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Hydroxychloroquine imports from India.
People Also Ask — Hydroxychloroquine Supplier & Trade Network
Who are the top suppliers of Hydroxychloroquine from India?+
Which companies buy Hydroxychloroquine from Indian manufacturers?+
Where does Hydroxychloroquine exported from India go?+
What is the market share of the top Hydroxychloroquine supplier from India?+
What is the average shipment value for Hydroxychloroquine exports from India?+
Is Hydroxychloroquine manufactured in India and exported globally?+
Which country imports the most Hydroxychloroquine from India?+
Who are the buyers of Hydroxychloroquine in United Kingdom?+
How concentrated is the Hydroxychloroquine supplier market in India?+
How do I find verified buyers for Hydroxychloroquine in specific countries?+
Hydroxychloroquine Trade Network — Key Takeaways
- 1ZYDUS LIFESCIENCES LIMITED is India's dominant Hydroxychloroquine exporter with a 78.3% market share and $110.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 163 suppliers collectively account for 89.7% of all tracked Hydroxychloroquine exports, with a combined trade value of $141.5M.
- 3United States is the largest destination market, absorbing 89.2% of India's Hydroxychloroquine exports ($126.2M). United Kingdom (1.9%) and Thailand (1.5%) follow.
- 4With 3.7K total shipments averaging $38.1K each, the Hydroxychloroquine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include EVERSANA LIFE SCIENCES SERVICES LLC, NORTHSTAR DISTRIBUTION CENTER 8912, EVERSANA LIFE SCIENCES SERVICES LLC, NORTHSTAR DISTRIBUTION CENTER 8912 — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 86 countries
Network value: $141.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Hydroxychloroquine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Hydroxychloroquine.
- 2.Flow Mapping: 163 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,717 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 86 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,717 Verified Shipments
163 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists